A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
RecruitingNCT07420803Phase: NAStarted 2026-03-23
Summary
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous va
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Mayo Clinic in FloridaJacksonville, Florida, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07420803